磷脂酸磷酸酶LPIN3抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 磷脂酸磷酸酶LPIN3抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Humans lipodystrophy is characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. Mice carrying mutations in the fatty liver dystrophy (fld) gene have similar phenotypes. Through positional cloning, the mouse gene responsible for fatty liver dystrophy was isolated and designated Lpin1. The nuclear protein encoded by 磷脂酸磷酸酶LPIN3抗体Lpin1 was named lipin. Lpin1 mRNA was expressed at high levels in adipose tissue and was induced during differentiation of preadipocytes. These results indicated that lipin is required for normal adipose tissue development and provided a candidate gene for human lipodystrophy. Through database searches, mouse and human EST and genomic sequences with similarities to Lpin1 were identified. These included two related mouse genes (Lpin2 and Lpin3) and three human homologs (LPIN1, LPIN2, and LPIN3). Human LPIN1 gene has been mapped to 2p25.磷脂酸磷酸酶LPIN3抗体; linkages of fat mass and serum leptin levels to this same region have been noted. Human LPIN2 and LPIN3 mapped to chromosomes 18p11 and 20q11-q12, respectively. The mouse genes encoding Lpin1, Lpin2, and Lpin3 mapped to chromosome 12, 17, and 2, respectively. [provided by RefSeq, Jul 2008]

磷脂酸磷酸酶LPIN3抗体Also known as:

dJ450M14.2; dJ450M14.3; dJ620E11.2; Lipin 3 like; Lipin-3; Lipin-3-like; Lipin3; LIPN3L; LPIN 3; LPIN3; LPIN3_HUMAN; Phosphatidate phosphatase LPIN3; RP4 620E11.3; SMP2.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Rabbit, .

●

Immunogen: KLH conjugated synthetic peptide derived from human Lipin 3.

●

磷脂酸磷酸酶LPIN3抗体Predicted Molecular Weight: 94kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl212Hu01基质金属蛋白酶23B(MMP23B)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 23B (MMP23B)

kl212Mu01基质金属蛋白酶23B(MMP23B)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 23B (MMP23B)

kl212Po01基质金属蛋白酶23B(MMP23B)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 23B (MMP23B)

kl212Ra01基质金属蛋白酶23B(MMP23B)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 23B (MMP23B)

kl213Bo01髓细胞触发受体1(TREM1)多克隆抗体Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

kl213Hu01髓细胞触发受体1(TREM1)多克隆抗体Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

kl213Mu01髓细胞触发受体1(TREM1)多克隆抗体Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

kl213Po01髓细胞触发受体1(TREM1)多克隆抗体Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

kl213Ra01髓细胞触发受体1(TREM1)多克隆抗体Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

kl214Bo01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Ca01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Cp01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Eq01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Ga01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Hu01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Mu01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Po01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Ra01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Rb51窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)

kl214Si01窖蛋白(CAV1)多克隆抗体Polyclonal Antibody to Caveolin 1 (CAV1)